Comprehensive proteomic analysis of human bile

Proteomics

Volumn 11, Issue 23, 2011, Pages 4443-4453

  Barbhuiya, Mustafa A ^a,b   Sahasrabuddhe, Nandini A ^b,c,d   Pinto, Sneha M ^b,c   Muthusamy, Babylakshmi ^b,e   Singh, Tekcham D ^a   Nanjappa, Vishalakshi ^b   Keerthikumar, Shivakumar ^b,h   Delanghe, Bernard ^f   Harsha, H C ^b   Chaerkady, Raghothama ^b,d   Jalaj, Visvajit ^g   Gupta, Sanjeev ^g   Shrivastav, Braj R ^g   Tiwari, Pramod K ^a   Pandey, Akhilesh ^d  

^a JIWAJI UNIVERSITY   (India)

^b Institute of Bioinformatics   (India)

^c MANIPAL UNIVERSITY   (India)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e PONDICHERRY UNIVERSITY   (India)

^f THERMO FISHER SCIENTIFIC   (Germany)

^g Cancer Hospital and Research Institute   (India)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bile; Biliary system; Body fluid proteomics; High resolution mass spectrometry; Technology

Indexed keywords

BILE ACID; BILE SALT; BIOLOGICAL MARKER; PROTEOME;

ARTICLE; BILE; BILE DUCT CANCER; BODY FLUID; CHEMICAL COMPOSITION; CONTROLLED STUDY; FRACTIONATION; GALLBLADDER CANCER; HEPATOBILIARY SYSTEM; HUMAN; ION EXCHANGE CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; LIVER CANCER; MASS SPECTROMETRY; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS;

ADULT; BILE; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; PROTEOME; PROTEOMICS;

EID: 81855185410     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100197     Document Type: Article

References (77)

1. Kristiansen, T. Z., Maitra, A., Pandey, A., Proteomics of Human Bile, Humana Press, New Jersey 2007, pp. 399-414.
2. Shrikhande, S. V., Barreto, S. G., Singh, S., Udwadia, T. E., Agarwal, A. K., Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause. Eur. J. Surg. Oncol. 2010, 36, 514-519.
3. Randi, G., Malvezzi, M., Levi, F., Ferlay, J. et al., Epidemiology of biliary tract cancers: an update. Ann. Oncol. 2009, 20, 146-159.
4. Andreotti, G., Hou, L., Gao, Y. T., Brinton, L. A. et al., Reproductive factors and risks of biliary tract cancers and stones: a population-based study in Shanghai, China. Br. J. Cancer 2010, 102, 1185-1189.
5. Lazcano-Ponce, E. C., Miquel, J. F., Munoz, N., Herrero, R. et al., Epidemiology and molecular pathology of gallbladder cancer. CA J. Clin. Cancer 2001, 51, 349-364.
6. Guglielmi, A., Ruzzenente, A., Campagnaro, T., Pachera, S. et al., Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J. Surg. 2009, 33, 1247-1254.
7. Bertran, E., Heise, K., Andia, M. E., Ferreccio, C., Gallbladder cancer: incidence and survival in a high-risk area of Chile. Int. J. Cancer 2010, 127, 2446-2454.
8. Liu, T., Qian, W. J., Gritsenko, M. A., Xiao, W. et al., High dynamic range characterization of the trauma patient plasma proteome. Mol. Cell. Proteomics 2006, 5, 1899-1913.
9. Thadikkaran, L., Siegenthaler, M. A., Crettaz, D., Queloz, P. A. et al., Recent advances in blood-related proteomics. Proteomics 2005, 5, 3019-3034.
10. Adachi, J., Kumar, C., Zhang, Y., Olsen, J. V., Mann, M., The human urinary proteome contains more than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006, 7, R80.
11. de Souza, G. A., Godoy, L. M., Mann, M., Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 2006, 7, R72.
12. Pilch, B., Mann, M., Large-scale and high-confidence proteomic analysis of human seminal plasma. Genome Biol. 2006, 7, R40.
13. Molina, H., Bunkenborg, J., Reddy, G. H., Muthusamy, B. et al., A proteomic analysis of human hemodialysis fluid. Mol. Cell. Proteomics 2005, 4, 637-650.
14. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
15. Kristiansen, T. Z., Bunkenborg, J., Gronborg, M., Molina, H. et al., A proteomic analysis of human bile. Mol. Cell. Proteomics 2004, 3, 715-728.
16. Reuben, A., Biliary proteins. Hepatology 1984, 4, 46S-50S.
17. Keulemans, Y. C., Mok, K. S., de Wit, L. T., Gouma, D. J., Groen, A. K., Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients. Hepatology 1998, 28, 11-16.
18. He, C., Fischer, S., Meyer, G., Muller, I., Jungst, D., Two-dimensional electrophoretic analysis of vesicular and micellar proteins of gallbladder bile. J. Chromatogr. A 1997, 776, 109-115.
19. Zhou, H., Chen, B., Li, R. X., Sheng, Q. H. et al., Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach. Rapid Commun. Mass Spectrom. 2005, 19, 3569-3578.
20. Guerrier, L., Claverol, S., Finzi, L., Paye, F. et al., Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins. J. Chromatogr. A 2007, 1176, 192-205.
21. Farina, A., Dumonceau, J. M., Frossard, J. L., Hadengue, A. et al., Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. J. Proteome Res. 2009, 8, 159-169.
22. Farina, A., Dumonceau, J. M., Delhaye, M., Frossard, J. L. et al., A step further in the analysis of human bile proteome. J. Proteome Res. 2011, 10, 2047-2063.
23. Farid, S. G., Craven, R. A., Peng, J., Bonney, G. K. et al., Shotgun proteomics of human bile in hilar cholangiocarcinoma. Proteomics 2011, 11, 2134-2138.
24. Harsha, H. C., Molina, H., Pandey, A., Quantitative proteomics using stable isotope labeling with amino acids in cell culture. Nat. Protoc. 2008, 3, 505-516.
25. Rappsilber, J., Mann, M., Ishihama, Y., Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2007, 2, 1896-1906.
26. Chaerkady, R., Harsha, H. C., Nalli, A., Gucek, M. et al., A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J. Proteome Res. 2008, 7, 4289-4298.
27. Kandasamy, K., Pandey, A., Molina, H., Evaluation of several MS/MS search algorithms for analysis of spectra derived from electron transfer dissociation experiments. Anal Chem 2009, 81, 7170-7180.
28. Cline, M. S., Smoot, M., Cerami, E., Kuchinsky, A. et al., Integration of biological networks and gene expression data using Cytoscape. Nat. Protoc. 2007, 2, 2366-2382.
29. Maere, S., Heymans, K., Kuiper, M., BiNGO: A Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21, 3448-3449.
30. Prasad, T. S., Kandasamy, K., Pandey, A., Human Protein Reference Database and Human Proteinpedia as discovery tools for systems biology. Methods Mol. Biol. 2009, 577, 67-79.
31. Kandasamy, K., Keerthikumar, S., Goel, R., Mathivanan, S. et al., Human Proteinpedia: a unified discovery resource for proteomics research. Nucleic Acids Res. 2009, 37, D773-D781.
32. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
33. Cocucci, E., Racchetti, G., Meldolesi, J., Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19, 43-51.
34. Pisitkun, T., Shen, R. F., Knepper, M. A., Identification and proteomic profiling of exosomes in human urine. Proc. Natl. Acad. Sci. USA 2004, 101, 13368-13373.
35. Skog, J., Wurdinger, T., van Rijn, S., Meijer, D. H. et al., Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 2008, 10, 1470-1476.
36. Mathivanan, S., Lim, J. W., Tauro, B. J., Ji, H. et al., Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol. Cell. Proteomics 2010, 9, 197-208.
37. Chuang, Y. H., Lan, R. Y., Gershwin, M. E., The immunopathology of human biliary cell epithelium. Semin. Immunopathol. 2009, 31, 323-331.
38. Samulin, J., Berget, I., Lien, S., Sundvold, H., Differential gene expression of fatty acid binding proteins during porcine adipogenesis. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 2008, 151, 147-152.
39. Hashimoto, T., Kusakabe, T., Sugino, T., Fukuda, T. et al., Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis. Pathobiology 2004, 71, 267-273.
40. Shi, Y. E., Ni, J., Xiao, G., Liu, Y. E. et al., Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res. 1997, 57, 3084-3091.
41. Nevo, J., Mai, A., Tuomi, S., Pellinen, T. et al., Mammary-derived growth inhibitor (MDGI) interacts with integrin alpha-subunits and suppresses integrin activity and invasion. Oncogene 2010, 29, 6452-6463.
42. Slany, A., Haudek, V. J., Zwickl, H., Gundacker, N. C. et al., Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B. J. Proteome Res. 2010, 9, 6-21.
43. Mullock, B. M., Shaw, L. J., Fitzharris, B., Peppard, J. et al., Sources of proteins in human bile. Gut 1985, 26, 500-509.
44. Kapoor, V. K., Cholecystectomy in patients with asymptomatic gallstones to prevent gall bladder cancer - the case against. Indian J. Gastroenterol. 2006, 25, 152-154.
45. Afdhal, N. H., Niu, N., Nunes, D. P., Bansil, R. et al., Mucin-vesicle interactions in model bile: evidence for vesicle aggregation and fusion before cholesterol crystal formation. Hepatology 1995, 22, 856-865.
46. Vilkin, A., Nudelman, I., Morgenstern, S., Geller, A. et al., Gallbladder inflammation is associated with increase in mucin expression and pigmented stone formation. Dig. Dis. Sci. 2007, 52, 1613-1620.
47. Shoda, J., Kano, M., Asano, T., Irimura, T. et al., Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitis. Hepatology 1999, 29, 1026-1036.
48. Ichikawa, H., Imano, M., Takeyama, Y., Shiozaki, H., Ohyanagi, H., Involvement of osteopontin as a core protein in cholesterol gallstone formation. J. Hepatobiliary Pancreat. Surg. 2009, 16, 197-203.
49. Imano, M., Satou, T., Itoh, T., Takeyama, Y. et al., An immunohistochemical study of osteopontin in pigment gallstone formation. Am. Surg. 2010, 76, 91-95.
50. Fuchs, M., Hafer, A., Münch, C., Kannenberg, F. et al., Disruption of the sterol carrier protein 2 gene in mice impairs biliary lipid and hepatic cholesterol metabolism. J. Biol. Chem. 2001, 276, 48058-65480.
51. Fuchs, M., Lammert, F., Wang, D. Q., Paigen, B. et al., Sterol carrier protein 2 participates in hypersecretion of biliary cholesterol during gallstone formation in genetically gallstone-susceptible mice. Biochem. J. 1998, 15, 33-37.
52. Cui, N. Q., Zhang, S. K., Cui, Y. F., Li, D. H. et al., Overexpression of sterol carrier protein-2 mRNA in patients with cholesterol gallstones. Hepatobiliary Pancreat. Dis. Int. 2005, 4, 117-120.
53. Cui, Y., Li, Z., Zhao, E., Jia, Y., Overexpression of Sterol Carrier Protein 2 in patients with hereditary cholesterol gallstones. BMC Gastroenterol. 2011, 11, 10.
54. Yokoyama, T., Komori, A., Nakamura, M., Takii, Y. et al., Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways. Liver Int. 2006, 26, 467-476.
55. Ayres, R. C., Neuberger, J. M., Shaw, J., Joplin, R., Adams, D. H., Intercellular adhesion molecule-1 and MHC antigens on human intrahepatic bile duct cells: effect of pro-inflammatory cytokines. Gut 1993, 34, 1245-1249.
56. Yang, J. M., O'Neill, P., Jin, W., Foty, R. et al., Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim. J. Biol. Chem. 2006, 281, 9719-9727.
57. Sidhu, S. S., Nawroth, R., Retz, M., Lemjabbar-Alaoui, H. et al., EMMPRIN regulates the canonical Wnt/beta-catenin signaling pathway, a potential role in accelerating lung tumorigenesis. Oncogene 2010, 29, 4145-4156.
58. Madigan, M. C., Kingsley, E. A., Cozzi, P. J., Delprado, W. J. et al., The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression. Cancer Immunol. Immunother. 2008, 57, 1367-1379.
59. Xie, H., Rhodus, N. L., Griffin, R. J., Carlis, J. V., Griffin, T. J., A catalogue of human saliva proteins identified by free flow electrophoresis-based peptide separation and tandem mass spectrometry. Mol. Cell. Proteomics 2005, 4, 1826-1830.
60. Techasen, A., Loilome, W., Namwat, N., Takahashi, E. et al., Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Cancer Sci. 2010, 101, 658-665.
61. Trzpis, M., McLaughlin, P. M., de Leij, L. M., Harmsen, M. C., Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am. J. Pathol. 2007, 171, 386-395.
62. Okegawa, T., Pong, R. C., Li, Y., Hsieh, J. T., The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim. Pol. 2004, 51, 445-457.
63. de Boer, C. J., van Krieken, J. H., Janssen-van Rhijn, C. M., Litvinov, S. V., Expression of Ep-CAM in normal, regenerating, metaplastic, and neoplastic liver. J. Pathol. 1999, 188, 201-206.
64. Kristiansen, T. Z., Harsha, H. C., Gronborg, M., Maitra, A., Pandey, A., Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma. J. Proteome Res. 2008, 7, 4670-4677.
65. Adams, D. H., Hubscher, S. G., Shaw, J., Johnson, G. D. et al., Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 1991, 14, 426-431.
66. He, L., Zhang, J., Jiang, L., Jin, C. et al., Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis. Mol. Carcinog. 2010, 49, 882-891.
67. Sawabu, T., Seno, H., Kawashima, T., Fukuda, A. et al., Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol. Carcinog. 2007, 46, 155-164.
68. Ip, C. K., Cheung, A. N., Ngan, H. Y., Wong, A. S., p70 S6 kinase in the control of actin cytoskeleton dynamics and directed migration of ovarian cancer cells. Oncogene 2011, 30, 2420-2432.
69. Arias-Romero, L. E., Villamar-Cruz, O., Pacheco, A., Kosoff, R. et al., A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells. Oncogene 2010, 29, 5839-5849.
70. Junttila, T. T., Laato, M., Vahlberg, T., Söderström, K. O., Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients. Clin. Cancer Res. 2003, 9, 5346-5357.
71. Scartozzi, M., Galizia, E., Freddari, F., Berardi, R., Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches. Cancer Treat. Rev. 2004, 30, 451-459.
72. Akiba, J., Ogasawara, S., Kawahara, A., Nishida, N. et al., N-myc downstream regulated gene 1 (NDRG1)/Cap43 enhances portal vein invasion and intrahepatic metastasis in human hepatocellular carcinoma. Oncol. Rep. 2008, 20, 1329-1335.
73. Jiang, K., Shen, Z., Ye, Y., Yang, X., Wang, S., A novel molecular marker for early detection and evaluating prognosis of gastric cancer: N-myc downstream regulated gene-1 (NDRG1). Scand. J. Gastroenterol. 2010, 45, 898-908.
74. Hao, Z., Li, X., Qiao, T., Li, S. et al., Downregulated expression of CIAPIN1 may contribute to gastric carcinogenesis by accelerating cell proliferation and promoting cell cycle progression. Cancer Biol Ther 2009, 8, 1064-1070.
75. Zheng, X., Zhao, Y., Wang, X., Li, Y. et al., Decreased expression of CIAPIN1 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma. Dig. Dis. Sci. 55, 3408-3414.
76. Piao, D., Jiang, T., Liu, G., Wang, B., Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer. Mol. Biol. Rep. 2011, 5, 1-8.
77. Kahlert, C., Weber, H., Mogler, C., Bergmann, F., Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse. Br. J. Cancer. 2009, 101, 457-464.